↓
JAVASCRIPT IS DISABLED. Please enable JavaScript on your browser to best view this site.
Hosts Jack West & Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform for systemic therapy, especially immunotherapy, in early stage cancer & pathologic response assessment from surgery. (41:04)
Audio Podcast
August 31, 2021 by BeaconMedIC
Posted in Beyond the Journal Podcast
Tagged Abramson Cancer Center , AccessHope , Beacon Medical Interchange , BeaconMedIC , Beyond the Journal , BTJ , Cancer , CheckMate 816 , chemoimmunotherapy , City of Hope Comprehensive Cancer Center , Dr. Charu Aggarwal , Dr. Howard (Jack) West , Education , Health , immunotherapy , Johns Hopkins , Leslye M Heisler Associate Professor of Medicine , Medicine , NADIM , neoadjuvant therapy , nivolumab , Oncology , path CR , pathologic complete response , Patrick Forde , pCR , preoperative therapy , residual cancer burden , Science , Sidney Kimmel Cancer Center , University of Pennsylvania School of Medicine
Copyright © now=new Date;theYear=now.getFullYear();document.write(theYear) Beacon Medical Interchange – All Rights Reserved | WordPress Design by Mark Lindsey – CCWD
↑
